CMS needs to strengthen its internal controls to ensure Part B drug payment accuracy, OIG finds

The Office of the Inspector General within HHS today called on the Centers for Medicare & Medicaid Services (and CMS agreed) to improve the accuracy of its Medicare Part B drug payment data.